Key facts
- This page summarizes Mark Voll's Form 4 filing for RenovoRx, Inc. (RNXT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 21 May 2026, 07:00.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
No transaction description listed
Additional SEC filing notes
Footnote F1
Reflects open market purchases of the Issuer's securities.
Footnote F2
A grant of 58,953 restricted stock units ("RSUs") was previously reported for the Reporting Person's future service as the Chief Financial Officer of the Issuer, subject to monthly vesting with the RSUs valued based on the closing price on the last trading day of the month in which the services were performed. As of April 30, 2026, 8,823 of such RSUs had vested, leaving a remaining balance of 50,130 unvested RSUs.